UNI-EN 21:SPHTRCurrent report 21 re insiders transactions
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| | UNI - EN REPORT No | 21 | / | 2016 | | ||||||
| Date of issue: | 2016-02-22 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| SPHTRCurrent report 21 re insiders transactions | |||||||||||
| Official market - legal basis | |||||||||||
| Art. 160 ust 4 Ustawy o obrocie - informacja o transakcjach osуb maj№cych dostкp do informacji poufnych | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Sopharma AD (the “Company") announces that it was notified by Mr. Ognian Donev, Chairman of the Board of Directors that the company “Sopharma Trading AD" related to him, executed the following transactions related to shares in the Company: Date and time of the settlement Operation Number of shares Unit price (BGN) 19.2.2016 Buy 75 2.5950 19.2.2016 Buy 4 2.6440 19.2.2016 Buy 196 2.6440 22.2.2016 Buy 85 2.6400 22.2.2016 Buy 115 2.6400 22.2.2016 Buy 100 2.6050 23.2.2016 Buy 2 000 2.6230 23.2.2016 Buy 500 2.6200 23.2.2016 Buy 100 2.6770 The transfer of the above-mentioned shares was executed on the Bulgarian Stock Exchange in Sofia (regulated market) by way of electronic trade. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| SPHTRCurrent report 21 re insiders transactions.doc SPHTRCurrent report 21 re insiders transactions.doc | SPHTRCurrent report 21 re insiders transactions | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2016-02-22 | Ognian Donev | Executive director | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to 5.88 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
